Status:
COMPLETED
Long-term Adverse Effects After Bariatric Surgery on Oesophagus Epithelium
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Morbid Obesity
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this trial is to examine long-term effects of laparoscopic gastric bypass (LRYGB) and sleeve gastrectomy (LSG) on oesophageal symptoms and disease, including the presence of Barrett oesoph...
Detailed Description
Bariatric surgery shows impressive results in terms of weight loss and resolution of comorbidities. Still, there are questions as to the frequency of long-term adverse effects: the prevalence and caus...
Eligibility Criteria
Inclusion
- Patients who received laparoscopic gastric bypass or laparoscopic sleeve gastrectomy ≥ 5 years ago as a primary bariatric procedure will be eligible for this study.
Exclusion
- Patients who received laparoscopic gastric bypass or laparoscopic sleeve gastrectomy as a secondary bariatric procedure (e.g. after gastric banding),
- Patients who received a secondary bariatric operation after laparoscopic gastric bypass or laparoscopic sleeve gastrectomy( e.g. biliopancreatic diversion)
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT03410849
Start Date
February 1 2018
End Date
September 1 2020
Last Update
November 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Claraspital
Basel, Switzerland, 4016